Optimizing Cardiovascular Treatment in Non-Small Cell Lung Cancer: A Comprehensive Computational Approach for Assessment of Drug-Drug Interactions Between Tyrosine Kinase Inhibitors and Cardiovascular Drugs [version 2; peer review: 2 approved, 1 approved with reservations]
Background As lung cancer treatment has progressed, there has been an increase in awareness of the short- and long-term adverse effects of targeted cancer therapies of tyrosine kinase inhibitors, particularly cardiovascular toxicities. Methods The current study assessed the potential drug-drug inter...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
F1000 Research Ltd
2025-10-01
|
| Seri Bilgileri: | F1000Research |
| Konular: | |
| Online Erişim: | https://f1000research.com/articles/14-309/v2 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|